MRVI Maravai Lifesciences Holdings PE ratio, current and historical analysis
The current PE ratio of MRVI cannot be calculated, as the latest EPS of -$1.64 is negative. The last PE ratio of Maravai Lifesciences Holdings, recorded in September 2023, was 55.56.
MRVI PE ratio history
The PE ratio of Maravai Lifesciences Holdings has averaged 15.98 over the last four years. Looking back at the last four years, MRVI's PE ratio peaked in the Sep 2023 quarter at 55.56, when the price was $10 and the EPS was $0.18. The lowest point was in the Dec 2020 quarter, when it reached 3.78 with a price of $28.05 and an EPS of $7.43.
Maravai Lifesciences Holdings PE ratio by year
Maximum annual increase: 597.09% in 2021
Maximum annual decrease: -67.48% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | 8.57 | -67.48% |
| 2021 | 26.35 | 597.09% |
| 2020 | 3.78 | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
MRVI average PE ratio chart
MRVI PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| NBIX Neurocrine Biosciences Inc | 36.1 | $14.11B |
| NVAX Novavax Inc | N/A | $1.34B |
| NVCR NovoCure Ltd | N/A | $3.36B |
| MRVI Maravai Lifesciences Holdings Inc | N/A | $1.38B |
Frequently asked questions
What is Maravai Lifesciences Holdings's PE ratio?
The current price to earnings ratio of MRVI cannot be determined, as its EPS of -$1.64 is negative.
What is the 3-year average PE ratio for Maravai Lifesciences Holdings (MRVI)?
The average PE ratio for MRVI stock over the past 3 years is 21.53.
What is the highest PE ratio for MRVI?
Over the last four years, the quarterly PE ratio reached its highest level at 55.56 in the Sep 2023 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.